AT511508T - Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent

40 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims
Document	Office	Kind	Date
2000367757	Japan	A	2000-12-01
0110462	Japan	W	2001-11-30

Family members, oldest first
Document	Office	Kind
CA2436825A1	Canada	A1	2002-06-06
WO0244167A1	World Intellectual Property Organization (WIPO)	A1	2002-06-06
AU1850602A	Australia	A	2002-06-11
JP2002226478A	Japan	A	2002-08-14
NO20032437D0	Norway	D0	2003-05-28
KR20030060967A	Republic of Korea	A	2003-07-16
NO20032437L	Norway	L	2003-07-17
EP1337525A1	European Patent Office (EPO)	A1	2003-08-27
HK1054380A	Hong Kong, China	A	2003-11-28
CN1478086A	China	A	2004-02-25
US2004049045A1	United States of America	A1	2004-03-11
HU0400781A2	Hungary	A2	2004-07-28
HUP0400781A2	Hungary	A2	2004-07-28
PL362801A1	Poland	A1	2004-11-02
CN1254473C	China	C	2006-05-03
US7285668B2	United States of America	B2	2007-10-23
TWI290922B	Taiwan Province of China	B	2007-12-11
NO326019B1	Norway	B1	2008-09-01
JP4160293B2	Japan	B2	2008-10-01
US2008306118A1	United States of America	A1	2008-12-11
KR20090003348A	Republic of Korea	A	2009-01-09
KR100887912B1	Republic of Korea	B1	2009-03-12
KR20100002278A	Republic of Korea	A	2010-01-06
KR100939948B1	Republic of Korea	B1	2010-02-04
HU0400781A3	Hungary	A3	2010-03-29
HUP0400781A3	Hungary	A3	2010-03-29
CA2436825C	Canada	C	2011-01-18
EP1337525B1	European Patent Office (EPO)	B1	2011-06-01
AT511508TThis record	Austria	T	2011-06-15
ATE511508T1	Austria	T1	2011-06-15
EP2345650A1	European Patent Office (EPO)	A1	2011-07-20
PT1337525E	Portugal	E	2011-09-01
DK1337525T3	Denmark	T3	2011-09-19
EP1337525B8	European Patent Office (EPO)	B8	2011-10-05
ES2367419T3	Spain	T3	2011-11-03
HK1054380B	Hong Kong, China	B	2012-01-27
PL399787A1	Poland	A1	2012-11-05
PL214684B1	Poland	B1	2013-09-30
HU229356B1	Hungary	B1	2013-11-28
PL409463A1	Poland	A1	2016-02-15

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2012-01-15	Publication of translation of european patent specificationUEP	UEP

CPC, 10: C07D401/12
A61K9/5026
A61K9/5078
A61K31/44
A61P1/00
A61P1/02
A61P1/04
A61P7/04
A61P31/04
A61P35/00
Filled: the office’s first classification
IPC, 8: A61K31 44
A61K9 50
A61P1 00
A61P1 04
A61P31 04
A61P35 00
A61P7 04
C07D401 12

Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent